Stiris Research Inc. announces addition of a Director, Clinical Science

London, ON & Cambridge, MA — May 13, 2019 —

Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announce the addition of Carrie Hamilton, BSc. to the Clinical team.

Carrie joins the company as the Director, Clinical Science and brings 30 years’ of biopharmaceutical experience with an expansive understanding of the industry from product discovery and development to post-marketing patient access. Carrie’s global experience, therapeutic expertise, quality relationships with top KOLs and patient-centric focus will bring value to our clients.

“Carrie is a results-oriented, dynamic leader who excels at developing strategic and purposeful relationships with internal and external stakeholders”, said Amanda Carrera, Vice President of Stiris Research.  “Her ability to truly listen to a client’s challenge and work with them to develop a plan or solution is one of the things that makes Carrie such a strong leader and invaluable asset to our clients.”

Carrie’s therapeutic expertise: endocrinology, hematology, neurology, oncology and the rare and orphan disease space.

About Stiris Research

Stiris Research is an entrepreneurial Clinical Trial Management company specializing in conducting complex Phase I through IIIB trials for North American biotechnology and biopharmaceutical companies, with a focus on Oncology, CNS and Neurology. Stiris Research was formed as a result of listening to the stakeholders engaged in clinical trials, identifying their unmet needs, and developing a unique, value-based approach to address those needs.

For more information, please contact:

Marketing – Stiris Research Inc.